Pharmaceutical Full Disclosure Act.

HB 75, the Pharmaceutical Full Disclosure Act, requires prescription drug manufacturers to clearly disclose specific information in advertisements targeting North Carolina consumers. It mandates that ads include the FDA approval date for the drug's use, the date the drug first became available to U.S. consumers, and detailed clinical trial data for required side effects (such as trial length, participant numbers, and side effect frequency). The law applies to all advertisements via TV, internet, print, or radio in North Carolina published on or after October 1, 2025, directly affecting drug manufacturers and their marketing materials. This policy change aims to provide clearer, evidence-based information about prescription drugs in promotional content.